GAP-f (@GAP_f_Network) header
GAP-f (@GAP_f_Network) profile picture

The GAP-f Network is hosted by WHO and was created to address the gap in paediatric medicines through coordination and collaboration among key stakeholders

Geneva, Switzerland
Joined April 2021
Photo by GAP-f (@GAP_f_Network)Photo by GAP-f (@GAP_f_Network)Photo by GAP-f (@GAP_f_Network)Photo by GAP-f (@GAP_f_Network)Photo by GAP-f (@GAP_f_Network)Photo by GAP-f (@GAP_f_Network)Photo by GAP-f (@GAP_f_Network)Photo by GAP-f (@GAP_f_Network)Photo by GAP-f (@GAP_f_Network)Photo by GAP-f (@GAP_f_Network)
Many essential medicines are not designed for children. That means crushed pills, inaccurate doses, and bitter tastes that make treatment hard to take. @GAP_f_Network is working to close this gap. 🔗bit.ly/4lkpLZk #HealthForAll
16
68
5
161
35,576
Too many children are given medicines that were never properly tested for them. That means imprecise dosing—and real risks. 💡 The @GAP_f_Network is changing the game. They’re fast-tracking the development of medicines made for children—not just scaled-down versions of adult treatments. Check it out: bit.ly/4lkpLZk
20
43
4
123
34,456
The @GAP_f_Network is improving access to medicines designed for children — but it can’t do it alone. It takes a village. Ensuring children get access to the medicines they need means working hand-in-hand with communities, countries, regulators, funders, private sector entities, and health care professionals.
12
21
79
44,721
The new strategy to invest in children’s health by @GAP_f_Network sets a clear direction for 2030: 🔹 Focus on the most urgent diseases 🔹 Speed up access to key medicines 🔹 Strengthen the paediatric medicines ecosystem A $40M investment means lives saved with no time lost.
15
31
2
111
55,267
🌍This #WorldPneumoniaDay, we must address the ongoing battle against #RSV, a leading cause of severe respiratory infections in young children👩🏾‍🍼👦🏾🧒🏾. 🧐RSV causes a potentially life-threatening disease that kills over 1⃣0⃣0⃣'0⃣0⃣0⃣ children each year, with 9⃣7⃣% of these deaths occurring in low- and middle-income countries. 📰Our recent commentary in @LancetGH highlights the urgent need for strategies to prevent severe RSV infections in infants. By ensuring the availability of long-acting RSV-monoclonal antibodies, we can: ✅bridge the healthcare equity gap and ✅significantly reduce the burden of severe RSV infections and associated mortality. 🔗bit.ly/3A33ooy @Stop_Pneumonia @wellcometrust @IAVI @unitaid @ReSViNET #BetterMeds4Kids #RSVPrevention #GlobalHealth
1
4
5
632
Children of all ages are overlooked in the global #AMR response🛑 Our new policy paper details the extent of this crisis and provides recommendations to ensure children are no longer left behind. Together we can help children survive and thrive 🌍 gardp.org/publications/survi…
10
1
19
3,768
Replying to @malik_farihah
Such important issue, from how discovery science is done, R&D, Clinical Trials, Formulations, Regulation & Access. Some progress in some areas, Malaria, HIV, but a systemic issue that needs range of partners to work together with combined voice @GAP_f_Network
3
1
5
721
✅Janet Ginnard of @UNITAID at #WHA77 #BetterMeds4Kids @GAP_f_Network event. 🎙️The research agenda needs to be informed by those in need and who will be taking the medicines 🤝Partnership among #publichealth organisations and communities is key 🚀The leadership of @WHO to ensure no kids are left behind has been instrumental.
1
3
5
370
🎙️@ABanerjeeWHO of @WHO describes the severe challenges that hamper the rapid development of pediatric formulations and explains why it is essential to continue our work for #BetterMeds4Kids 💪🏽. ‼️Member states are invited to enable access to essential safe quality medicines💊💉🧫 for pregnant women, mothers, newborns and children through accelerating implementation of the actions laid out in 2️⃣ resolutions. #WHA77
1
2
3
136
✅@penazzatom1 of @WHO explains how we could improve the clinical trial framework to include #kids. 👉🏽we need to utilise platform approaches so that studies can be implemented more rapidly. 👉🏽we need to shift the point of gravity in order to build on the capacity that is already there. 👉🏽we need to have a healthy financial ecosystem. Pharma companies might need to collaborate more strongly #WHA77 @GAP_f_Network event. #BetterMeds4Kids
1
2
3
154
Passionate advocacy for children by Florence Anam of @gnpplus. We must not forget those who are not at the table. #BetterMeds4Kids
1
2
2
86
@penazzatom1 of @GAP_f_Network outlines the importance of investing in clinical trial platforms to expedite the investigation of new products for children. #BetterMeds4Kids
2
3
3
1,499
#WHA77 @GAP_f_Network #BetterMeds4Kids event 👇🏼 🎙️@JeremyFarrar of @WHO reminds the audience that access to medicines for children is a major #globalhealth issue continously receiving widespread attention. The paediatric community cannot represent themselves at this Assembly taking place now in #Geneva so we have a huge responsibility! There have been progress but it is condition by condition. There are enormous benefits of bringing everybody together here to address the critical needs of children.
1
2
4
218
Starting now! @JeremyFarrar opens the side event discussing progress made on #BetterMeds4Kids and highlighting the power of collective partnerships along the lifecycle
We look forward to seeing many of you today on an important discussion on leadership and accountability to #bettermeds4kids. You can also register online to attend! 👇👇 who.zoom.us/webinar/register…
2
2
5
875
An exciting development for pediatric #antibiotics! This paper highlights the need to fast-track clinical trials for vital antibiotics for kids. Kudos to Shionogi for their progress in pediatric development and to @WHO & @GAP_f_Network for identifying priority antibiotics for kids. 👏 Together, we're advancing global health. #AMR #GlobalHealth
A new brief by GAP-f, @gardp_amr and @WHO highlights efforts to expand access to our antibiotic for Gram-negative bacterial infections among pediatric populations. ​ To read the brief, visit: iris.who.int/bitstream/handl…
6
16
1,306
Lack of inclusion of women and children in R&D delays access to treatments. We welcome the ongoing work of @GAP_f_Network to promote innovation of and #access2meds for children. Our intervention on maternal health & child mortality at the @WHO #EB154 ➡️dndi.org/statements/2024/dnd…
7
2
17
3,051
#IPHASA2023 #BetterMeds4Kids 👇🏾 🎙️Fatima Tsiouris of @EGPAF & 🎙️ MPP's @Seb_Morin_GVA representing @GAP_f_Network partners kick off the meeting. The Global Accelerator for Paediatric Formulations Network (GAP-f) is a @WHONetwork that was created to respond to the paediatric treatment gap. who.int/initiatives/gap-f
1
3
8
228
#HappeningNow #IPHASA2023 | Join us & @GAP_f_Network partners (@CHAI_health, @EGPAF, @teampata, @PEPFAR, @WHO) as we explore accelerating access to #BetterMeds4Kids👦🏽 Watch Live Here👇🏽 iphasa.org/live-room-1/
1
3
3
210
'R&D efforts urgently need to be streamlined and target the products that are most needed for kids. The PADO is a consensus-building process, to be sure that all... agree on the priorities for children.' @tizmasini at #ECTMIH2023. Read more about PADO ➡️bit.ly/49HPfud
3
17
1,149
On #WorldChildrensDay MPP reaffirms its commitment to addressing the needs of children 👶🏾👧🏾🧒🏾 across all disease areas in which it operates. 🤝🏾As a proud member of @GAP_f_Network, we ensure that the most-needed, optimal paediatric formulations are prioritised, developed & made available to #children in an 🚀accelerated manner. 👉🏾bit.ly/3QKXwVI #BetterMeds4Kids #PublicHealth #GlobalHealth
2
8
625